Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valrocemide (Teva/Acorda).

Collin A Hovinga1

  • 1Miami Children's Hospital, Research Institute/Brain Institute, 3100 SW 62nd Ave, Miami FL 33155, USA. cahovinga@aol.com

Current Opinion in Investigational Drugs (London, England : 2000)
|February 27, 2004
PubMed
Summary

Valrocemide, an anticonvulsant, is being developed for epilepsy treatment. Clinical trials are progressing, with investigations into bipolar disorder and neuropathic pain also underway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: A randomized split-body control study.

Pediatric dermatology·2019
Same author

Association Between Delusions of Infestation and Prescribed Narcotic and Stimulant Use.

Journal of psychiatric practice·2018
Same author

Thrombolysis in pediatric stroke study.

Stroke·2015
Same author

Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial.

Stroke·2014
Same author

Epigenetic analysis of neurocognitive development at 1 year of age in a community-based pregnancy cohort.

Behavior genetics·2014

Area of Science:

  • Pharmacology
  • Neurology
  • Clinical Trials

Background:

  • Valrocemide is an anticonvulsant medication.
  • It is under development by Teva and Acorda.
  • Epilepsy is a neurological disorder characterized by seizures.

Purpose of the Study:

  • To evaluate valrocemide as an adjunct therapy for refractory epilepsy.
  • To explore the potential of valrocemide in treating bipolar disorder.
  • To investigate valrocemide for neuropathic pain management.

Main Methods:

  • A Phase II clinical trial was conducted.
  • The trial focused on patients with refractory epilepsy.
  • Phase III trials were being planned.

Main Results:

  • The Phase II trial in refractory epilepsy patients was completed.
  • Results indicated potential for valrocemide as an adjunct therapy.
  • Further trials are necessary to confirm efficacy and safety.

Conclusions:

  • Valrocemide shows promise as an epilepsy treatment.
  • Further research is warranted for bipolar disorder and neuropathic pain.
  • Clinical development is advancing to Phase III trials.

Related Experiment Videos